Clinical Trials Browser

Phase 2 × Immunotherapy, Adoptive × Other hematologic neoplasm × Clear all

Burkitt Lymphoma, Leukemia, Lymphoma, Leukemia, Myeloid, Acute, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03068416 2021-10-20

CD19-targeting, 3rd Generation CAR T Cells for Refractory B Cells Malignancy

Phase 2 Completed

24 enrolled

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell

NCT03598179 2019-08-07

XLCART001 Treatment in Relapsed/Refractory/High-risk B-cell Malignancy Subjects

Phase 2 Unknown

10 enrolled

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell

Clinical Trials

273

CD19-targeting, 3rd Generation CAR T Cells for Refractory B Cells Malignancy

XLCART001 Treatment in Relapsed/Refractory/High-risk B-cell Malignancy Subjects